Target intelligence / Profile preview

Tissue heating by radiofrequency energy (null)

Target
null
Molecular classification
Other (physical process, not a molecule, receptor, or protein)
01

Overview

Tissue heating by radiofrequency energy refers to the increase in tissue temperature produced when RF electromagnetic fields are absorbed in biological tissues. The energy is primarily converted to heat through rapid oscillations of ions within cells (electromagnetic-to-mechanical energy conversion), resistive heating via current flow in tissue, and by thermal conduction from heated regions to adjacent tissue. This process is utilized in medicine for procedures like radiofrequency ablation to destroy unwanted tissue—for example, in cancer therapy or volume reduction. The temperature threshold for protein denaturation and cell death is typically around 55–65°C for mammalian tissues[1]. Safety concerns include unintended thermal injury, variations in individual tolerance (e.g., due to age, disease, or medication), and the difficulty in precisely controlling the affected tissue volume[1][3]. Tissue heating by RF energy is not a pharmacological target and has no associated molecular biomarkers or drug interactors; it is instead monitored through physical parameters such as temperature rise and thermal diffusion patterns[1][4].

Other names
RF-induced tissue heatingradiofrequency tissue heatingRF energy heating
02

Mechanism of action

Conversion of electromagnetic energy to heat (molecular agitation/friction); Resistive heating (current flow through tissue); Conductive heating (thermal energy transfer to adjacent tissues)

03

Biological functions

Physical tissue heatingProtein denaturation via thermal injuryCell death by hyperthermiaThermoregulation via blood flow, convection, conduction, and evaporation
04

Disease associations

Cancer therapy (ablation)Tissue reduction (otorhinolaryngology)Other (therapeutic ablation, imaging safety concerns)
05

Safety considerations

Thermal injury to non-target tissuesDeep or uneven heating depending on tissue size and RF wavelengthRisk of burns, protein denaturation, cell deathIndividual variation due to underlying health or medicationThermoregulatory failure, especially at high exposure or impaired physiologyInduction of malignant transformation if ablation incomplete

Beyond the preview

Go deeper on Tissue heating by radiofrequency energy (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue heating by radiofrequency energy (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call